The Director will lead evidence generation strategies to support optimal patient access for breast cancer medicines, focusing on Atirmociclib. Responsibilities include coordinating inputs from local teams, executing HEOR studies, developing launch deliverables, and partnering with stakeholders for strategic dissemination of HEOR materials.